How can I manage my severe osteoporosis at age 61 as a woman?

Question

Hello doctor,

I am a 61-year-old woman who was diagnosed with severe osteoporosis after sustaining a compression fracture of my L1(lumbar 1) vertebra from simply bending over to pick up groceries. My DEXA(dual-energy X-ray absorptiometry) scan results were alarming, with T-scores of:

Lumbar spine: -3.8.
Femoral neck: -3.2.
Total hip: -3.4.

My 10-year fracture risk calculated by FRAX(fracture risk assessment tool)is 35% for major osteoporotic fractures and 12% for hip fractures. I went through early menopause at the age of 47 without receiving hormone replacement therapy. My vitamin D level was critically low at 8 nanograms per milliliter, and my parathyroid hormone level is elevated at 88 picograms per milliliter, suggesting secondary hyperparathyroidism.

I have been taking Alendronate (Bisphosphonate class) 70 mg weekly for approximately eight months, along with calcium 1500 mg daily and vitamin D 3000 IU(international unit) daily. However, my bone turnover markers remain elevated, with CTX(C-terminal telopeptide) at 720 picograms per milliliter. The bisphosphonate causes severe esophageal irritation and heartburn despite my following proper administration instructions.

I am terrified of falling and breaking my hip, as my mother did; she never recovered and passed away within a year of her fracture. My recent spine X-ray shows early wedging of T12, suggesting another compression fracture may be developing.

Please suggest.

Should I switch to a more potent medication such as Zoledronic Acid infusions?
Should I consider anabolic agents such as Teriparatide?
Are there other lifestyle modifications beyond weight-bearing exercise that I should adopt?

I have stopped most physical activities because of my fear of fractures, but I realize this may be making my condition worse.

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I have read your query and can understand your concern.

You are facing a severe and active form of osteoporosis that requires more aggressive and targeted management. The T-scores from your DEXA (dual-energy X-ray absorptiometry) can confirm very low bone density, and your history of a low-trauma compression fracture at L1, along with early wedging at T12, suggests ongoing skeletal fragility.

The elevated fracture risk from your FRAX (fracture risk assessment tool) score and critically low vitamin D level, combined with secondary hyperparathyroidism, indicate that your bones are under continuous metabolic stress. Alendronate (bisphosphonate class) is often a first-line therapy. Still, given your significant esophageal side effects and persistently elevated bone turnover markers such as CTX (C-terminal telopeptide), it may no longer be appropriate for you.

Zoledronic Acid (Bisphosphonate class), an intravenous medication, could be the next step as it avoids gastrointestinal irritation and provides once-yearly dosing with potent antiresorptive effects.

However, in your case, an anabolic agent such as Teriparatide (parathyroid hormone analog class) or Abaloparatide (parathyroid hormone analog class) may be more suitable because they actively stimulate bone formation, which is crucial in someone with multiple fractures and severely reduced bone mass.

These therapies can significantly reduce the risk of vertebral and non-vertebral fractures when used early in high-risk patients like yourself. After one to two years on an anabolic, you can transition to an antiresorptive agent to maintain the bone gained.

Lifestyle modifications beyond weight-bearing exercise include balance training such as Tai Chi or gentle, supervised physical therapy to improve stability and prevent falls. Home safety assessments, using hip protectors, and reviewing all medications that may affect balance or bone metabolism are also necessary. It is critical not to avoid all movement out of fear, as inactivity can further weaken bones and muscles.

I hope this helps.

Thank you.